Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Phenylalanine Hydroxylase
Taylor, Geoffrey
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Caldwell, Christina
Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. Cancer Prev Res (Phila). 2014 Dec; 7(12):1198-209.
View in:
PubMed
subject areas
Animals
Apoptosis
Blotting, Western
Carcinoma, Pancreatic Ductal
Cell Proliferation
Disease Progression
Eflornithine
Female
Humans
Immunoenzyme Techniques
Male
Mice
Mice, Inbred C57BL
Mutation
Ornithine Decarboxylase
Ornithine Decarboxylase Inhibitors
Pancreatic Neoplasms
Proto-Oncogene Proteins p21(ras)
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Signal Transduction
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
authors with profiles
Venkateshwar Rao Chinthalapally
Venkateshwar Madka